Russia advances in the approval of its vacuna Sputnik V before the World Health Organization, which would allow agencies in other countries or regions such as the United States, Canada and the European Union to endorse the use of the drug and at the same time, recognize the travel certificates of people with this immune system, particularly those that come from Mexico.
More than 440 million doses of the drug have been distributed worldwide. vacuna Sputnik V. In fact, it is one of those that has been distributed in Latin America.
Until this past September 26, 6 million 900 thousand doses had arrived in our country in 16 shipments, from the Gamaleya National Center for Epidemiology and Microbiology Research, which would represent that at least 3.5 million Mexican women or men have received this vaccine.
Recently, the United States announced that as of November it will only allow entry to its borders of people who have the complete vaccination scheme of any of the six vaccines that have already been authorized by the WHO and the Food and Drug Administration (FDA ): Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, Moderna, Sinopharm, and Sinovac. Not so in the case of those who have Sputnik V, Novavax, Abdala and Soberana.
The same occurs with the European Union, which allows the entry of travelers only with a complete scheme of vaccines authorized by the World Health Organization, which is not the case of the one produced in Russia.
In this regard, Mexico, through the Ministry of Foreign Affairs, has called for nations to recognize the immunological certificates of this vaccine that is already being applied successfully not only here but also in 70 other nations of the world.
PROGRESS BEFORE WHO
According to the Sputnik V official site, this weekend in Geneva, Switzerland, Russian Health Minister Mikhail Murashko announced the removal of all obstacles to the recognition of the Russian vaccine by the WHO.
“To date all barriers have been removed, so today we do not see any obstacles to our work. And this was confirmed by the Director General [de la OMS]”, Emphasized the minister.
Murashko said that the applicant company should sign some papers and provide a number of additional documents. The application would then be considered during an administrative procedure. “Only minor administrative procedures remain,” he said.
He added that the minister spoke in Geneva with representatives of the United States and other countries about the recognition of travel certificates: “This is the beginning of a constructive dialogue,” he said about the mutual recognition of vaccination certificates.
“They listened to the arguments; they understand that it is rational because approving a vaccine for sale in the market and approving a drug as prophylaxis against Covid-19 are two different processes,” Murashko said.
In addition, the head of the Ministry of Health of the Russian Federation stated that in the WHO negotiations, the management of the health system, the mechanisms to stabilize the situation in the world and ensure the protection of the population of many states, including countries in Africa, Asia, and Latin America.